ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 683556 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 683556; 2) Community: the network communities that were significantly associated with the response to NSC 683556; 3) Molecule: the relationships between components within communities and NSC 683556; 4) MDR: the compounds that were significantly associated with the NSC 683556.

NSC Compound Enrichment Correlation
NSC 655105 Cycloshikonin 0.049093561024907 0.14870713
NSC 668300 Null 0.049093561024907 0.08928254
NSC 670802 Null 0.049093561024907 0.15807485
NSC 671030 N8-Actinomycin D 0.049093561024907 0.25836686
NSC 672055 Null 0.049093561024907 -0.064569172
NSC 677942 L-Glutamamide, N(2)-[4-[[(2,4-diamino-6-pteridinyl)methyl](methyl)amino]benzoyl]-N(1),N(5)-didecyl- 0.049093561024907 -0.053556385
NSC 759857 Clofarabine (USAN) 3.90447589578875e-005 0.62720801
NSC 606497 Camptothecin Derivative 4.07740039933618e-005 0.86030059
NSC 700363 Liposomal Annamycin 4.07740039933618e-005 0.64389125
NSC 634724 10,11-methylenedioxycamptothecin 5.82211804338771e-005 0.83732427
Total:51  Current:50    [First] [Prev] [Next] [Last]